We are live on
!
Find out more
Syndax Pharmaceuticals
SNDX
SNDX
75 hedge funds and large institutions have $124M invested in Syndax Pharmaceuticals in 2018 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 28 increasing their positions, 19 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
536% more call options, than puts
Call options by funds: $4.8M | Put options by funds: $755K
47% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 19
17% more capital invested
Capital invested by funds: $106M → $124M (+$18M)
4.61% more ownership
Funds ownership: 61.05% → 65.66% (+4.6%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 84 → 75 (-9)
41% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 22
Holders
75
Holders Change
-9
Holders Change %
-10.71%
% of All Funds
1.71%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
28
Reduced
19
Closed
22
Calls
$4.8M
Puts
$755K
Net Calls
+$4.05M
Net Calls Change
+$4.11M
Top Buyers
| 1 |
Millennium Management
New York
|
+$3.27M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.69M |
| 3 |
Renaissance Technologies
New York
|
+$1.69M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.21M |
| 5 |
6CM
683 Capital Management
New York
|
+$1.04M |
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$2.38M |
| 2 |
JP Morgan Chase
New York
|
-$1.9M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.51M |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.39M |
| 5 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
-$929K |
